Tsubota Laboratory Incorporated

4890

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-12FY2027 Q1

Revenue

3.9100M JPY

YoY -71.2%

Operating Income

-1.7100M JPY

YoY +21.6%

Net Income

-6.9100M JPY

YoY -489.3%

EPS

-5.2JPY

YoY +33.2%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

13.6億円

8.2億円

2.8億円

-2.5億円

-7.9億円

Rev: 6.4億円Op: 1.4億円NI: 1.5億円

Rev: 9.5億円Op: 1.7億円NI: 90.2百万円

Rev: 6.7億円Op: -6.5億円NI: -6.4億円

Rev: 13.6億円Op: 2.4億円NI: 2.1億円

Rev: 2億円Op: -7.9億円NI: -7.6億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income-

Revenue Progress2.100M

Revenue Forecast-

Net Income Progress-

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan